SCHEMBL1798449

SCHEMBL1798449

COC(=O)c1cc(OCc2ccccc2)ccc1NC(=O)COCC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.53
TSHR P16473 2/20 0.53
HSD17B10 Q99714 2/20 0.53
MAPK10 P53779 2/20 0.53
RAB9A P51151 5/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
NPC1 O15118 3/20 0.52
KDM4E B2RXH2 4/20 0.47
MAOB P27338 1/20 0.46
PKM P14618 1/20 0.46
HCAR2 Q8TDS4 1/20 0.46
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
POLB P06746 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SIRT2 Q8IXJ6 1/20 0.45
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22213558 0.85 MEN1 (0.64) ALDH1A1TSHRHSD17B10MAPK10RAB9A
SCHEMBL1797985 0.84 ALDH1A1 (0.47) ALDH1A1TSHRHSD17B10MAPK10RAB9A
SCHEMBL4895612 0.83 BRD4 (0.57) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL1799563 0.81 KDM4E (0.52) ALDH1A1TSHRHSD17B10MAPK10KDM4E
SCHEMBL1796940 0.81 SERPINE1 (0.63) ALDH1A1TSHRHSD17B10MAPK10RAB9A
SCHEMBL2609089 0.79 MAOB (0.50) ALDH1A1RAB9ASMN1; SMN2NPC1KDM4E
SCHEMBL1015370 0.78 KDM4E (0.60) ALDH1A1TSHRHSD17B10MAPK10SMN1; SMN2
SCHEMBL1796641 0.78 ALDH1A1 (0.57) ALDH1A1TSHRHSD17B10MAPK10KDM4E
SCHEMBL1800306 0.78 TSHR (0.51) ALDH1A1TSHRHSD17B10MAPK10KDM4E
SCHEMBL16632075 0.78 ALDH1A1 (0.60) ALDH1A1TSHRHSD17B10MAPK10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 ALDH1A1 800/4885TSHR 2186/4885HSD17B10 1614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.